CMRI and CCT serve as valuable, accurate, and safe noninvasive imaging modalities for the diagnosis and management of ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
CMRI and CCT may aid ischemic cardiomyopathy diagnosis and screening; leaves open optimal clinical integration pending prospective validation.
Ischemic cardiomyopathy is one of the major health problems worldwide, representing a significant part of mortality in the general population nowadays. Cardiac magnetic resonance imaging (CMRI) and cardiac computed tomography (CCT) are noninvasive imaging methods that serve as useful tools in the diagnosis of coronary artery disease and may also help in screening individuals with risk factors for developing this illness. Technological developments of CMRI and CCT have contributed to the rise of several clinical indications of these imaging methods complementarily to other investigation methods, particularly in cases where they are inconclusive. In terms of accuracy, CMRI and CCT are similar to the other imaging methods, with few absolute contraindications and minimal risks of adverse side-effects. This fact strengthens these methods as powerful and safe tools in the management of patients. The present study is aimed at describing the role played by CMRI and CCT in the diagnosis of ischemic cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Assunção et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: